Target intelligence / Profile preview

ZNF426 divergent transcript (ZNF426-DT)

Target
ZNF426-DT
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

ZNF426 divergent transcript (ZNF426-DT), also known as CTC-543D15.8, is classified as a long non-coding RNA (lncRNA). It does not encode a protein and is not currently characterized as a therapeutic target, receptor, enzyme, transporter, or transcription factor. There is limited information on its specific biological function, involvement in disease, or potential as a biomarker or drug target in major annotation resources. ZNF426-DT is annotated as a lncRNA gene, located on chromosome 19 (chr19:9538665-9539742, hg38). No protein-coding function or established role as a receptor, enzyme, or other classical drug target type is currently assigned. There are no known drugs, biomarkers, or associated mechanisms of action listed for this gene in primary gene-centric databases. While ZNF426 (Zinc Finger Protein 426) is a protein-coding gene functioning as a transcriptional repressor, ZNF426-DT is a distinct non-coding transcript overlapping or near the ZNF426 locus, and should not be confused with the protein-coding gene. ZNF426 divergent transcript (ZNF426-DT; CTC-543D15.8) is a long non-coding RNA, with no current evidence supporting its use as a therapeutic target, association with disease, or function as a receptor, enzyme, transporter, or transcription factor according to the main available resources.

Other names
CTC-543D15.8ZNF426-DT
02

Biological functions

Other (no specific biological function currently defined in widely used literature or annotation databases)
03

Disease associations

Other (no established association with specific disease roles in available databases)

Beyond the preview

Go deeper on ZNF426 divergent transcript (ZNF426-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZNF426 divergent transcript (ZNF426-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call